Prospective Study of the Prognostic Value of New Markers in Adults With ALK-positive Large Anaplastic Lymphoma
Clinical trial NCT03603847 · COMPLETED
Trial details
- NCT number
- NCT03603847
- Sponsor
- The Lymphoma Academic Research Organisation
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-08-02
- Primary completion
- 2023-06-16
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.